MicroRNA-134 plasma levels before and after treatment for bipolar mania.
about
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disordersTherapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderRole of MicroRNA in Governing Synaptic PlasticityNoncoding RNAs and neurobehavioral mechanisms in psychiatric diseaseMicroRNAs in the pathophysiology and treatment of status epilepticusMicroRNAs as biomarkers for CNS diseaseThe potential utility of pharmacogenetic testing in psychiatryThe Emerging Role of microRNAs in Schizophrenia and Autism Spectrum DisordersCirculating miRNAs profiles in Tourette syndrome: molecular data and clinical implications.MicroRNAs in Experimental Models of Movement Disorders.Noninvasive micromarkersHigh dose glargine alters the expression profiles of microRNAs in pancreatic cancer cellsHeterogeneity and individuality: microRNAs in mental disorders.MicroRNAs: Meta-controllers of gene expression in synaptic activity emerge as genetic and diagnostic markers of human diseaseAcute stress alters amygdala microRNA miR-135a and miR-124 expression: inferences for corticosteroid dependent stress response.Horizons of psychiatric genetics and epigenetics: where are we and where are we heading?Evidence demonstrating role of microRNAs in the etiopathology of major depressionPreliminary investigation of miRNA expression in individuals at high familial risk of bipolar disorder.Circulating microRNA-144-5p is associated with depressive disorders.In vivo microRNA detection and quantitation in cerebrospinal fluid.A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancerSpecific Roles of MicroRNAs in Their Interactions with Environmental Factors.microRNAs as Biomarker in Depression PathogenesisXenomiRs and miRNA homeostasis in health and disease: evidence that diet and dietary miRNAs directly and indirectly influence circulating miRNA profiles.Genome-wide analysis reveals downregulation of miR-379/miR-656 cluster in human cancersA plasma microRNA signature of acute lentiviral infection: biomarkers of central nervous system disease.MicroRNA as therapeutic targets for treatment of depression.Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologiesIncreased miR-132 level is associated with visual memory dysfunction in patients with depression.Bipolar Disorder Associated microRNA, miR-1908-5p, Regulates the Expression of Genes Functioning in Neuronal Glutamatergic Synapses.Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma.Genetic variation in the miR-708 gene and its binding targets in bipolar disorder.Newer insights into the role of miRNA a tiny genetic tool in psychiatric disorders: focus on post-traumatic stress disorder.Transcripts involved in calcium signaling and telencephalic neuronal fate are altered in induced pluripotent stem cells from bipolar disorder patients.Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications.Response to treatment in bipolar disorder.Functions of noncoding RNAs in neural development and neurological diseases.Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases.Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs.Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases.
P2860
Q21129476-72596074-1265-4C80-85B4-82323BADAD4FQ24626017-60F2465E-6A77-418F-826C-C1E67DEAF378Q26748978-07217EEC-CE05-4704-9242-A7CDBB036BA2Q26851626-713FE025-2AE5-4ECC-BAA1-5AD4530B263BQ27004814-F4A853A6-0D3B-4384-BA57-B56232FC0C18Q27013998-F69D44F2-3330-44F8-9D6B-43D74BDFC3DCQ28084874-C20F828C-41E9-47D3-A6FF-203C2D048381Q28112165-0555B731-2C71-4D30-B927-4ED1C9EE9D46Q30982356-9547BE7C-0140-4FD6-AEC2-87023C75268EQ33636313-F9FBCD50-2F4E-422A-B79E-4930AC9D7BFDQ34111606-4E81189C-F02A-4089-8055-83D8C308B096Q34280758-589536E7-F0D8-4C96-B5A9-33C55612D330Q34447816-61F1EF1B-B813-4FBC-A6D7-FD953CB2D7B0Q34594189-32B5E570-A037-4135-9AD2-1890C17D641EQ34984406-E85E20B4-EDCC-448E-BB3B-CD0736ACF790Q35177686-55D61C4E-773C-4CCF-B6CB-5BDB1FC29C44Q35186527-C27E05B8-464A-405B-ADB3-DD12D33B4B6FQ35232290-BECC7BA8-97C6-453F-9800-EE3E53B8C21BQ35871861-F35BA69B-E931-4F6E-B565-D6EF8D2885D0Q35992237-3A68FFFE-9C8B-4E35-A0BE-1683B340145BQ36038792-03E06C8B-B63F-4D0B-B3BC-EA5C0EA3B6C0Q36411230-CD3BB09E-AC7F-4762-846C-FE4C0D256080Q36584886-2C65BE11-385F-4266-A541-BD96E659231BQ36631208-3D3CDADD-8F4F-4996-A788-5214689B7E6EQ36923020-2CB2D4D5-82F9-4A91-81AA-5583EFFB6426Q36989920-7B65B7E3-8263-4219-B610-B7FACC7A1468Q37075039-BF5853C5-284E-4530-9E70-E40079926ED7Q37158033-EB932C50-DA01-4E48-967F-BC3A55096EEFQ37413049-411CC474-52AC-461E-A555-A947A016E207Q37541356-D958CFD6-1F7E-417C-9D5F-5C91E76BB81EQ37549962-B3A42516-89EA-42CD-81C6-7023F03E86E0Q37593741-73146365-7353-4110-9C2B-6AED0306F38CQ37648299-ED188268-CE56-4719-B571-C0E834D8A3EBQ37663637-E66395C8-7869-48F3-9C76-71AC816F486CQ37699995-4D7EE94B-4099-489F-AAD5-D7A44B27FA4EQ37810764-8598DEA6-0EF1-4E73-9B80-9DFF2858836FQ37942074-C47BAA20-8D71-4314-BE9B-9E21BD21FF44Q38018832-ADF7ED99-C5F1-4BD4-A21B-05EEF77F3956Q38068561-13CC6C99-D69A-4DEB-8CA5-061796ABB23DQ38103194-54B784BB-E450-40DF-8DC7-2D03F68E5C9B
P2860
MicroRNA-134 plasma levels before and after treatment for bipolar mania.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
MicroRNA-134 plasma levels before and after treatment for bipolar mania.
@ast
MicroRNA-134 plasma levels before and after treatment for bipolar mania.
@en
MicroRNA-134 plasma levels before and after treatment for bipolar mania.
@nl
type
label
MicroRNA-134 plasma levels before and after treatment for bipolar mania.
@ast
MicroRNA-134 plasma levels before and after treatment for bipolar mania.
@en
MicroRNA-134 plasma levels before and after treatment for bipolar mania.
@nl
prefLabel
MicroRNA-134 plasma levels before and after treatment for bipolar mania.
@ast
MicroRNA-134 plasma levels before and after treatment for bipolar mania.
@en
MicroRNA-134 plasma levels before and after treatment for bipolar mania.
@nl
P2093
P1476
MicroRNA-134 plasma levels before and after treatment for bipolar mania.
@en
P2093
Chang An Chao
Chun Pin Liao
Dong Hui Wu
Hai Chen Yang
He Zen Yang
Kong Jun Yang
P356
10.1016/J.JPSYCHIRES.2010.04.028
P577
2010-05-23T00:00:00Z